EyeSense GmbH ^Company

EyeSense was founded in 2006 as a spin off of CIBA Vision, a subsidiary of the Novartis Group. As early as 2007, successful clinical trials were being performed with the first eye sensor prototypes. The eye sensor is currently at an advanced prototype stage. Since 2010, EyeSense haі concentrated efforts on the development of a continuous glucose monitoring system. In 2011 and 2012, two successful clinical trials were conducted using prototypes for the CGM System. Since 2013, EyeSense has been working to bring the CGM System to series production status. In 2017 two more successful clinical trials were conducted using close –to-production prototypes also under home use conditions.